Akashi Therapeutics Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 3

Akashi Therapeutics General Information

Description

Operator of a biopharmaceutical company intended to develop treatments for Duchenne muscular dystrophy and other rare pediatric diseases. The company's treatments promote healthy muscle regeneration and build muscle mass and strength, enabling patients to transform their situations from a fatal, aggressive muscle-wasting disease to a chronic, manageable condition.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 245 First Street
  • 18th Floor
  • Cambridge, MA 02142
  • United States
+1 (617)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 245 First Street
  • 18th Floor
  • Cambridge, MA 02142
  • United States
+1 (617)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Akashi Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Secondary Transaction - Private 01-Mar-2022 Completed Generating Revenue
3. Early Stage VC (Series A1) 03-Jul-2014 Completed Generating Revenue
2. Grant $1M $6M Completed Generating Revenue
1. Early Stage VC (Series A) 10-Apr-2013 $6M $6M Completed Generating Revenue
To view Akashi Therapeutics’s complete valuation and funding history, request access »

Akashi Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A1
Series A
To view Akashi Therapeutics’s complete cap table history, request access »

Akashi Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biopharmaceutical company intended to develop treatments for Duchenne muscular dystrophy and other rare pe
Drug Discovery
Cambridge, MA
2 As of 2020

Cambridge, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Akashi Therapeutics Competitors (1)

One of Akashi Therapeutics’s competitors is AOBiome Therapeutics, a Formerly VC-backed company based in Cambridge, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
AOBiome Therapeutics Formerly VC-backed Cambridge, MA
You’re viewing 1 of 1 competitors. Get the full list »

Akashi Therapeutics Patents

Akashi Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20160250188-A1 Methods for treatment of muscular dystrophies Inactive 25-Oct-2013
US-20190167640-A1 Methods for treatment of muscular dystrophies Inactive 25-Oct-2013
AU-2013237881-A1 Dosage forms of halofuginone and methods of use Active 29-Mar-2012
AU-2013237881-B2 Dosage forms of halofuginone and methods of use Inactive 29-Mar-2012
AU-2018200167-A1 Dosage forms of halofuginone and methods of use Inactive 29-Mar-2012 A61K9/4891
To view Akashi Therapeutics’s complete patent history, request access »

Akashi Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Akashi Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Hadasit Venture Capital Minority
Charley's Fund Not-For-Profit Venture Capital
Nash Avery Foundation Other
To view Akashi Therapeutics’s complete investors history, request access »

Akashi Therapeutics Acquisitions (2)

Akashi Therapeutics’s most recent deal was a Merger/Acquisition with Tonus Therapeutics. The deal was made on 15-Sep-2014.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Tonus Therapeutics 15-Sep-2014 Merger/Acquisition Drug Discovery
Collgard Biopharmaceuticals 01-Mar-2011 Merger/Acquisition Pharmaceuticals
To view Akashi Therapeutics’s complete acquisitions history, request access »

Akashi Therapeutics FAQs

  • When was Akashi Therapeutics founded?

    Akashi Therapeutics was founded in 2010.

  • Where is Akashi Therapeutics headquartered?

    Akashi Therapeutics is headquartered in Cambridge, MA.

  • What is the size of Akashi Therapeutics?

    Akashi Therapeutics has 2 total employees.

  • What industry is Akashi Therapeutics in?

    Akashi Therapeutics’s primary industry is Drug Discovery.

  • Is Akashi Therapeutics a private or public company?

    Akashi Therapeutics is a Private company.

  • What is Akashi Therapeutics’s current revenue?

    The current revenue for Akashi Therapeutics is .

  • How much funding has Akashi Therapeutics raised over time?

    Akashi Therapeutics has raised $7.5M.

  • Who are Akashi Therapeutics’s investors?

    Hadasit, Charley's Fund, and Nash Avery Foundation have invested in Akashi Therapeutics.

  • Who are Akashi Therapeutics’s competitors?

    AOBiome Therapeutics is a competitor of Akashi Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process